New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: Microarray analysis of gene expression in a rat model

Arthritis Research and Therapy

Volumn 12, Issue 3, 2010, Pages

  Kerachian, Mohammad Amin ^a   Cournoyer, Denis ^a   Harvey, Edward J ^a   Chow, Terry Y ^a   Bégin, Louis R ^b   Nahal, Ayoub ^a   Séguin, Chantal ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; GLUCOCORTICOID; MESSENGER RNA; PREDNISONE; BIOLOGICAL MARKER; CDRAP PROTEIN, RAT; COL2A1 PROTEIN, RAT; COLLAGEN TYPE 2; CORTICOSTEROID; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AVASCULAR NECROSIS; BONE MARROW NECROSIS; CARTILAGE; CONTROL GROUP; DISEASE COURSE; DISEASE MARKER; EXON; FEMALE; FEMUR HEAD; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VALIDATION STUDY; ANIMAL; BONE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DNA MICROARRAY; DRUG EFFECT; FEMUR HEAD NECROSIS; GENETICS; METABOLISM; PATHOLOGY; WISTAR RAT;

ADRENAL CORTEX HORMONES; ALPHA-MACROGLOBULINS; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BONE AND BONES; COLLAGEN TYPE II; DISEASE MODELS, ANIMAL; FEMALE; FEMUR HEAD NECROSIS; GLUCOCORTICOIDS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; RATS; RATS, WISTAR;

EID: 79959862864     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3062     Document Type: Article

References (46)

1. Aaron RK, Ciombor DM. Coagulopathies and osteonecrosis. Curr Opin Orthop 2001, 12:378-383.
2. Chandler FA. Coronary disease of the hip. 1949. Clin Orthop Relat Res 2001, 386:7-10. 10.1097/00003086-200105000-00002, 11347850.
3. Asano T, Takahashi KA, Fujioka M, Inoue S, Okamoto M, Sugioka N, Nishino H, Tanaka T, Hirota Y, Kubo T. ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation. Pharmacogenetics 2003, 13:675-682. 10.1097/00008571-200311000-00003, 14583680.
4. Tektonidou MG, Moutsopoulos HM. Immunologic factors in the pathogenesis of osteonecrosis. Orthop Clin North Am 2004, 35:259-263. vii, 10.1016/j.ocl.2004.02.003, 15271533.
5. Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine 2006, 73:500-507. 10.1016/j.jbspin.2006.01.025, 16931094.
6. Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Séguin C. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 2006, 13:237-244. 10.1080/10623320600904211, 16990180.
7. Nobillot R, Le Parc JM, Benoit J, Paolaggi JB. Idiopathic osteonecrosis of the hip in twins. Ann Rheum Dis 1994, 53:702. 10.1136/ard.53.10.702, 1005441, 7979587.
8. Miyamoto Y, Matsuda T, Kitoh H, Haga N, Ohashi H, Nishimura G, Ikegawa S. A recurrent mutation in type II collagen gene causes Legg-Calve-Perthes disease in a Japanese family. Hum Genet 2007, 121:625-629. 10.1007/s00439-007-0354-y, 17394019.
9. Chen WM, Liu YF, Lin MW, Chen IC, Lin PY, Lin GL, Jou YS, Lin YT, Fann CS, Wu JY, Hsiao KJ, Tsai SF. Autosomal dominant avascular necrosis of the femoral head in two Thaiwanese pedigress and linkage to chromosome 12q13. Am J Hum Genet 2004, 75:310-317. 10.1086/422702, 1216065, 15179599.
10. Liu YF, Chen WM, Lin YF, Yang RC, Lin MW, Li LH, Chang YH, Jou YS, Lin PY, Su JS, Huang SF, Hsiao KJ, Fann CS, Hwang HW, Chen YT, Tsai SF. Type II collagen gene variants and inherited osteonecrosis of the femoral head. N Engl J Med 2005, 352:2294-2301. 10.1056/NEJMoa042480, 15930420.
11. Boss JH, Misselevich I. Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals. Vet Pathol 2003, 40:345-354. 10.1354/vp.40-4-345, 12824505.
12. Ferrari P, Schroeder V, Anderson S, Kocovic L, Vogt B, Schiesser D, Marti HP, Ganz R, Frey FJ, Kohler HP. Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation 2002, 74:1147-1152. 10.1097/00007890-200210270-00016, 12438962.
13. Glueck CJ, Fontaine RN, Gruppo R, Stroop D, Sieve-Smith L, Tracy T, Wang P. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop Relat Res 1999, 366:133-146. 10.1097/00003086-199909000-00017, 10627727.
14. Jones JP. Coagulopathies and osteonecrosis. Acta Orthop Belg 1999, 65(Suppl 1):5-8.
15. Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ. Procoagulants and osteonecrosis. J Rheumatol 2003, 30:783.
16. Pósán E, Hársfalvi J, Szepesi K, Gáspár L, Batár P, Udvardy M. Increased platelet activation and decreased fibrinolysis in the pathogenesis of aseptic necrosis of the femoral head. Platelets 1998, 9:233-235. 10.1080/09537109876753, 16793708.
17. Hadjigeorgiou G, Dardiotis E, Dardioti M, Karantanas A, Dimitroulias A, Malizos K. Genetic association studies in osteonecrosis of the femoral head: mini review of the literature. Skeletal Radiol 2008, 37:1-7. 10.1007/s00256-007-0395-2, 17962936.
18. Asano T, Takahashi KA, Fujioka M, Inoue S, Ueshima K, Hirata T, Okamoto M, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo T. Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects. Transplantation 2004, 77:220-225. 10.1097/01.TP.0000101433.99651.96, 14742985.
19. Séguin C, Kassis J, Busque L, Bestawros A, Theodoropoulos J, Alonso ML, Harvey EJ. Non-traumatic necrosis of bone (osteonecrosis) is associated with endothelial cell activation but not thrombophilia. Rheumatology (Oxford) 2008, 47:1151-1155. 10.1093/rheumatology/ken206, 18524806.
20. Schulte CM, Beelen DW. Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter. Transplantation 2004, 78:1055-1063. 10.1097/01.TP.0000138026.40907.38, 15480174.
21. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002, 32:94-124.
22. Kerachian MA, Séguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 2009, 114:121-128. 10.1016/j.jsbmb.2009.02.007, 19429441.
23. Wada M, Kumagai K, Murata M, Yamashita Y, Shindo H. Warfarin reduces the incidence of osteonecrosis of the femoral head in spontaneously hypertensive rats. J Orthop Sci 2004, 9:585-590. 10.1007/s00776-004-0829-9, 16228676.
24. Arlet J. A Traumatic Necrosis Of The Femoral Head: General Report In Bone Circulation and Vascularization In Normal And Pathological Conditions 1993, 235-240. New York: Plenum Press.
25. Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 2000, 85:2907-2912. 10.1210/jc.85.8.2907, 10946902.
26. Shibahara M, Nishida K, Asahara H, Yoshikawa T, Mitani S, Kondo Y, Inoue H. Increased osteocyte apoptosis during the development of femoral head osteonecrosis in spontaneously hypertensive rats. Acta Med Okayama 2000, 54:67-74.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of Royal Statistical Society. Series B (Methodological) 1995, 57:289-300.
28. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998, 102:274-282. 10.1172/JCI2799, 508885, 9664068.
29. Kabata T, Kubo T, Matsumoto T, Nishino M, Tomita K, Katsuda S, Horii T, Uto N, Kitajima I. Apoptotic cell death in steroid induced osteonecrosis: an experimental study in rabbits. J Rheumatol 2000, 27:2166-2171.
30. Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 2000, 85:2907-2912. 10.1210/jc.85.8.2907, 10946902.
31. Kerachian MA, Cournoyer D, Nahal A, Harvey EJ, Chow TY, Séguin C. Apoptotic cell death in steroid-induced bone disease: A pilot study in rats. Bone 2007, 40:S287.
32. Mihara K, Hirano T. Standing is a causative factor in osteonecrosis of the femoral head in growing rats. J Pediatr Orthop 1998, 18:665-669. 10.1097/00004694-199809000-00022, 9746422.
33. Calder JD, Buttery L, Revell PA, Pearse M, Polak JM. Apoptosis--a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br 2004, 86:1209-1213. 10.1302/0301-620X.86B8.14834, 15568539.
34. O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 2004, 145:1835-1841. 10.1210/en.2003-0990, 14691012.
35. Jia D, O'Brien CA, Stewart SA, Manolagas SC, Weinstein RS. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 2006, 147:5592-5599. 10.1210/en.2006-0459, 1819400, 16935844.
36. Kerachian MA, Cournoyer D, Harvey EJ, Chow T, Séguin C. Isolation and characterization of human bone-derived endothelial cells. Endothelium 2007, 14:115-121. 10.1080/10623320701347062, 17497368.
37. Glueck CJ, Glueck HI, Mieczkowski L, Tracy T, Speirs J, Stroop D. Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?. Thromb Haemost 1993, 69:460-465.
38. Enghild JJ, Salvesen G, Brew K, Nagase H. Interaction of human rheumatoid synovial collagenase (matrix metalloproteinase 1) and stromelysin (matrix metalloproteinase 3) with human alpha 2-macroglobulin and chicken ovostatin. Binding kinetics and identification of matrix metalloproteinase cleavage sites. J Biol Chem 1989, 264:8779-8785.
39. Ramadori G, Knittel T, Schwögler S, Bieber F, Rieder H, Meyer zum Büschenfelde KH. Dexamethasone modulates alpha 2-macroglobulin and apolipoprotein E gene expression in cultured rat liver fat-storing (Ito) cells. Hepatology 1991, 14:875-882. 10.1002/hep.1840140520, 1718836.
40. Gordon AH, Limaos EA. Effects of bacterial endotoxin and corticosteroids on plasma concentrations of alpha 2 macroglobulin, haptoglobin and fibrinogen in rats. Br J Exp Pathol 1979, 60:434-440.
41. Luan Y, Kong L, Howell DR, LLalov K, Fajardo M, Bai XH, Di Cesare PE, Goldring MB, Abramson SB, Liu CJ. Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin. Osteoarthritis Cartilage 2008, 16:1413-1420. 10.1016/j.joca.2008.03.017, 2574789, 18485748.
42. Gavish H, Bab I, Tartakovsky A, Chorev M, Mansur N, Greenberg Z, Namdar-Attar M, Muhlrad A. Human alpha 2-macroglobulin is an osteogenic growth peptide-binding protein. Biochemistry 1997, 36:14883-14888. 10.1021/bi971670t, 9398211.
43. Zhang Y, Ge G, Greenspan DS. Inhibition of bone morphogenetic protein 1 by native and altered forms of alpha2-macroglobulin. J Biol Chem 2006, 281:39096-39104. 10.1074/jbc.M601362200, 17071617.
44. Becker CG, Harpel PC. alpha2-Macroglobulin on human vascular endothelium. J Exp Med 1976, 144:1-9. 10.1084/jem.144.1.1, 2190355, 58955.
45. Cvirn G, Gallistl S, Koestenberger M, Kutschera J, Leschnik B, Muntean W. Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C/protein S system in cord and adult plasma. Thromb Res 2002, 105:433-439. 10.1016/S0049-3848(02)00042-7, 12062545.
46. Beheiri A, Langer C, During C, Krumpel A, Thedieck S, Nowak-Göttl U. Role of elevated alpha2-macroglobulin revisited: results of a case-control study in children with symptomatic thromboembolism. J Thromb Haemost 2007, 5:1179-1184. 10.1111/j.1538-7836.2007.02534.x, 17403113.